| Literature DB >> 28038337 |
Niina Lapinlampi1, Esbjörn Melin2, Eleonora Aronica3, Jens P Bankstahl4, Albert Becker5, Cristophe Bernard6, Jan A Gorter3, Olli Gröhn1, Anu Lipsanen1, Katarzyna Lukasiuk7, Wolfgang Löscher8, Jussi Paananen9, Teresa Ravizza10, Paolo Roncon11, Michele Simonato11, Annamaria Vezzani10, Merab Kokaia2, Asla Pitkänen12.
Abstract
Lack of translation of data obtained in preclinical trials to clinic has kindled researchers to develop new methodologies to increase the power and reproducibility of preclinical studies. One approach relates to harmonization of data collection and analysis, and has been used for a long time in clinical studies testing anti-seizure drugs. EPITARGET is a European Union FP7-funded research consortium composed of 18 partners from 9 countries. Its main research objective is to identify biomarkers and develop treatments for epileptogenesis. As the first step of harmonization of procedures between laboratories, EPITARGET established working groups for designing project-tailored common data elements (CDEs) and case report forms (CRFs) to be used in data collection and analysis. Eight major modules of CRFs were developed, presenting >1000 data points for each animal. EPITARGET presents the first single-project effort for harmonization of preclinical data collection and analysis in epilepsy research. EPITARGET is also anticipating the future challenges and requirements in a larger-scale preclinical harmonization of epilepsy studies, including training, data management expertise, cost, location, data safety and continuity of data repositories during and after funding period, and incentives motivating for the use of CDEs.Entities:
Keywords: Common data element; Data management; Database; Epilepsy; Epileptogenesis
Mesh:
Substances:
Year: 2016 PMID: 28038337 DOI: 10.1016/j.eplepsyres.2016.11.010
Source DB: PubMed Journal: Epilepsy Res ISSN: 0920-1211 Impact factor: 3.045